Needham Downgrades Haemonetics (HAE) to Hold, 'Interventional Tech Likely to Weigh on FY27 Growth'
Tweet Send to a Friend
(Updated - December 15, 2025 6:26 AM EST)
Needham analyst Mike Matson downgraded Haemonetics (NYSE: HAE) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Mike Matson downgraded Haemonetics (NYSE: HAE) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
